Comparative Pharmacology
Head-to-head clinical analysis: ENTRESTO versus ENTRESTO SPRINKLE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ENTRESTO versus ENTRESTO SPRINKLE.
ENTRESTO vs ENTRESTO SPRINKLE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Entresto is a combination of sacubitril (a neprilysin inhibitor) and valsartan (an angiotensin II receptor blocker). Sacubitril inhibits neprilysin, increasing levels of natriuretic peptides and bradykinin, leading to vasodilation, natriuresis, and reduced sympathetic tone. Valsartan blocks AT1 receptors, reducing vasoconstriction, aldosterone release, and cardiac remodeling.
Sacubitril inhibits neprilysin, increasing natriuretic peptides; valsartan antagonizes angiotensin II type 1 receptor, causing vasodilation and reduced aldosterone.
Initial: 24 mg sacubitril/26 mg valsartan orally twice daily; double dose every 2-4 weeks to target maintenance of 97 mg sacubitril/103 mg valsartan twice daily.
Sacubitril/valsartan 24 mg/26 mg orally twice daily, doubled every 2-4 weeks to target 97 mg/103 mg twice daily.
None Documented
None Documented
Sacubitril: 1.4 hours; Sacubitrilat (active metabolite): 11.5 hours; Valsartan: 6.1 hours. The effective half-life for the ARNI effect is driven by sacubitrilat, allowing twice-daily dosing.
Terminal half-life: sacubitrilat ~11.5 hours; valsartan ~9.9 hours; in heart failure, effective half-life supports twice-daily dosing; accumulation minimal after steady state.
Approximately 51-68% of sacubitril and 37-48% of valsartan are excreted in urine; the remainder is eliminated in feces via biliary excretion.
Renal excretion: sacubitrilat ~52-68% unchanged; valsartan ~13% unchanged and ~80% as metabolites in feces via biliary excretion; total clearance of sacubitril is 52% renal, 48% fecal; valsartan clearance is primarily biliary (feces) with minor renal.
Category C
Category C
Angiotensin Receptor-Neprilysin Inhibitor (ARNI)
Angiotensin Receptor-Neprilysin Inhibitor (ARNI)